The location of the expression of the markers CD133, in the plasma membrane and the endoplasmic reticulum in stem cells, [17] and Oct4, expressed in the nucleus [18] suggests that while adenocarcinoma cells consist of pluripotent CSCs, hyperplasia consists of differentiating cells. The gene discussed is POU5F1; the disease is adenocarcinoma.